Conversely, inhibiting PLC activity adversely affects the activity of non-amyloidogenic γ-secretase (Rossner, 2004), casting doubt on PLC signaling’s role in mitigating amyloidogenesis in AD. The gene discussed is HSPG2; the disease is Alzheimer disease.